Funding
Public Grants & Research Funding
NIH grants supporting Hussein Yassine, MD's research on APOE, lipids, neuroinflammation, and Alzheimer's prevention — sourced from NIH RePORTER.
View all on NIH RePORTER4
Active Grants
12
Total PI Grants
NIH / NIA
Primary Funder
Current Funding
Active Grants
Drug Development for Alzheimer's neuroinflammation
View on NIH RePORTER →
Effect of diabetes and AD pathology on brain imaging and cognition in Latino adults
View on NIH RePORTER →
Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4
View on NIH RePORTER →
Research Education Component (REC) — University of Southern California Alzheimer's Disease Research Center
View on NIH RePORTER →
Grant History
Prior Grants
Alzheimer's Abeta, Tau, Apolipoproteins and Blood-brain barrier
View on NIH RePORTER →
ApoE, ABCA1 and endosomal dysregulation in AD
View on NIH RePORTER →
Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4 (Diversity Supplement)
View on NIH RePORTER →
The delivery of essential fatty acids to the Brain in Alzheimer's disease
View on NIH RePORTER →
Biomarkers of ABCA1 mediated functions in Alzheimer's disease
View on NIH RePORTER →
DHA brain delivery by APOE genotype
View on NIH RePORTER →
A Symposium on Nutrition State of Science for Dementia Prevention
View on NIH RePORTER →
The Effect of Saturated Fat Ingestion on the HDL Proteome
View on NIH RePORTER →
Hussein Yassine, MD's team leads NIH-funded research on drug development targeting cPLA2 neuroinflammation in Alzheimer's disease, including an $8 million U01 award (University of Southern California Today). Grant records reflect parent NIH awards as Principal Investigator.
Data sourced from reporter.nih.gov and University of Southern California Profiles.
